The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer Cells
{{output}}
Purpose: This study focused on combining irinotecan with Poly (ADP-ribose) polymerase (PARP) inhibitors to explore the potential for novel combination therapeutics in small cell lung cancer (SCLC). ... ...
